Iovance Biotherapeutics

Maria Fardis, President and CEO
Maria Fardis, President and CEO
USA | Funding: $1.6B (+)

Website: http://www.iovance.com/

IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL)